Hotline: +86-18022463983    020-85206863

Plasma Assays - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: 2024-11-19   |   Pages: 116   |   Tables: 182   |  Medical Care

The global market for Plasma Assays was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Plasma Assays, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Plasma Assays by region & country, by Type, and by Application.
The Plasma Assays market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasma Assays.
Market Segmentation
By Company
Abbott Diagnostics
Roche Diagnostics
Danaher Corporation
Bio-Rad Laboratories
Quest Diagnostics
Thermo Fisher Scientific
Biomerica
Becton Dickinson & Company
BioMerieux
Siemens Healthcare
Trinity Biotech
Segment by Type:
Complete Blood Count (CBC)
Glucose testing
Basic Metabolic Panel (BMP)
Blood Urea Nitrogen Testing (BUN)
Segment by Application
Hospitals
Clinics
Diagnostic Centres
Research Labs
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Plasma Assays manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Plasma Assays in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Plasma Assays in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:


Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

 

Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

 

Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

 

Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

 

Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

 

1 Market Overview
1.1 Plasma Assays Product Introduction
1.2 Global Plasma Assays Market Size Forecast
1.3 Plasma Assays Market Trends & Drivers
1.3.1 Plasma Assays Industry Trends
1.3.2 Plasma Assays Market Drivers & Opportunity
1.3.3 Plasma Assays Market Challenges
1.3.4 Plasma Assays Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Plasma Assays Players Revenue Ranking (2023)
2.2 Global Plasma Assays Revenue by Company (2019-2024)
2.3 Key Companies Plasma Assays Manufacturing Base Distribution and Headquarters
2.4 Key Companies Plasma Assays Product Offered
2.5 Key Companies Time to Begin Mass Production of Plasma Assays
2.6 Plasma Assays Market Competitive Analysis
2.6.1 Plasma Assays Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Plasma Assays Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Assays as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Complete Blood Count (CBC)
3.1.2 Glucose testing
3.1.3 Basic Metabolic Panel (BMP)
3.1.4 Blood Urea Nitrogen Testing (BUN)
3.2 Global Plasma Assays Sales Value by Type
3.2.1 Global Plasma Assays Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Plasma Assays Sales Value, by Type (2019-2030)
3.2.3 Global Plasma Assays Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Diagnostic Centres
4.1.4 Research Labs
4.2 Global Plasma Assays Sales Value by Application
4.2.1 Global Plasma Assays Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Plasma Assays Sales Value, by Application (2019-2030)
4.2.3 Global Plasma Assays Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Plasma Assays Sales Value by Region
5.1.1 Global Plasma Assays Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Plasma Assays Sales Value by Region (2019-2024)
5.1.3 Global Plasma Assays Sales Value by Region (2025-2030)
5.1.4 Global Plasma Assays Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Plasma Assays Sales Value, 2019-2030
5.2.2 North America Plasma Assays Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Plasma Assays Sales Value, 2019-2030
5.3.2 Europe Plasma Assays Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Plasma Assays Sales Value, 2019-2030
5.4.2 Asia Pacific Plasma Assays Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Plasma Assays Sales Value, 2019-2030
5.5.2 South America Plasma Assays Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Plasma Assays Sales Value, 2019-2030
5.6.2 Middle East & Africa Plasma Assays Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Plasma Assays Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Plasma Assays Sales Value
6.3 United States
6.3.1 United States Plasma Assays Sales Value, 2019-2030
6.3.2 United States Plasma Assays Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Plasma Assays Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Plasma Assays Sales Value, 2019-2030
6.4.2 Europe Plasma Assays Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Plasma Assays Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Plasma Assays Sales Value, 2019-2030
6.5.2 China Plasma Assays Sales Value by Type (%), 2023 VS 2030
6.5.3 China Plasma Assays Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Plasma Assays Sales Value, 2019-2030
6.6.2 Japan Plasma Assays Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Plasma Assays Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Plasma Assays Sales Value, 2019-2030
6.7.2 South Korea Plasma Assays Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Plasma Assays Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Plasma Assays Sales Value, 2019-2030
6.8.2 Southeast Asia Plasma Assays Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Plasma Assays Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Plasma Assays Sales Value, 2019-2030
6.9.2 India Plasma Assays Sales Value by Type (%), 2023 VS 2030
6.9.3 India Plasma Assays Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott Diagnostics
7.1.1 Abbott Diagnostics Profile
7.1.2 Abbott Diagnostics Main Business
7.1.3 Abbott Diagnostics Plasma Assays Products, Services and Solutions
7.1.4 Abbott Diagnostics Plasma Assays Revenue (US$ Million) & (2019-2024)
7.1.5 Abbott Diagnostics Recent Developments
7.2 Roche Diagnostics
7.2.1 Roche Diagnostics Profile
7.2.2 Roche Diagnostics Main Business
7.2.3 Roche Diagnostics Plasma Assays Products, Services and Solutions
7.2.4 Roche Diagnostics Plasma Assays Revenue (US$ Million) & (2019-2024)
7.2.5 Roche Diagnostics Recent Developments
7.3 Danaher Corporation
7.3.1 Danaher Corporation Profile
7.3.2 Danaher Corporation Main Business
7.3.3 Danaher Corporation Plasma Assays Products, Services and Solutions
7.3.4 Danaher Corporation Plasma Assays Revenue (US$ Million) & (2019-2024)
7.3.5 Bio-Rad Laboratories Recent Developments
7.4 Bio-Rad Laboratories
7.4.1 Bio-Rad Laboratories Profile
7.4.2 Bio-Rad Laboratories Main Business
7.4.3 Bio-Rad Laboratories Plasma Assays Products, Services and Solutions
7.4.4 Bio-Rad Laboratories Plasma Assays Revenue (US$ Million) & (2019-2024)
7.4.5 Bio-Rad Laboratories Recent Developments
7.5 Quest Diagnostics
7.5.1 Quest Diagnostics Profile
7.5.2 Quest Diagnostics Main Business
7.5.3 Quest Diagnostics Plasma Assays Products, Services and Solutions
7.5.4 Quest Diagnostics Plasma Assays Revenue (US$ Million) & (2019-2024)
7.5.5 Quest Diagnostics Recent Developments
7.6 Thermo Fisher Scientific
7.6.1 Thermo Fisher Scientific Profile
7.6.2 Thermo Fisher Scientific Main Business
7.6.3 Thermo Fisher Scientific Plasma Assays Products, Services and Solutions
7.6.4 Thermo Fisher Scientific Plasma Assays Revenue (US$ Million) & (2019-2024)
7.6.5 Thermo Fisher Scientific Recent Developments
7.7 Biomerica
7.7.1 Biomerica Profile
7.7.2 Biomerica Main Business
7.7.3 Biomerica Plasma Assays Products, Services and Solutions
7.7.4 Biomerica Plasma Assays Revenue (US$ Million) & (2019-2024)
7.7.5 Biomerica Recent Developments
7.8 Becton Dickinson & Company
7.8.1 Becton Dickinson & Company Profile
7.8.2 Becton Dickinson & Company Main Business
7.8.3 Becton Dickinson & Company Plasma Assays Products, Services and Solutions
7.8.4 Becton Dickinson & Company Plasma Assays Revenue (US$ Million) & (2019-2024)
7.8.5 Becton Dickinson & Company Recent Developments
7.9 BioMerieux
7.9.1 BioMerieux Profile
7.9.2 BioMerieux Main Business
7.9.3 BioMerieux Plasma Assays Products, Services and Solutions
7.9.4 BioMerieux Plasma Assays Revenue (US$ Million) & (2019-2024)
7.9.5 BioMerieux Recent Developments
7.10 Siemens Healthcare
7.10.1 Siemens Healthcare Profile
7.10.2 Siemens Healthcare Main Business
7.10.3 Siemens Healthcare Plasma Assays Products, Services and Solutions
7.10.4 Siemens Healthcare Plasma Assays Revenue (US$ Million) & (2019-2024)
7.10.5 Siemens Healthcare Recent Developments
7.11 Trinity Biotech
7.11.1 Trinity Biotech Profile
7.11.2 Trinity Biotech Main Business
7.11.3 Trinity Biotech Plasma Assays Products, Services and Solutions
7.11.4 Trinity Biotech Plasma Assays Revenue (US$ Million) & (2019-2024)
7.11.5 Trinity Biotech Recent Developments
8 Industry Chain Analysis
8.1 Plasma Assays Industrial Chain
8.2 Plasma Assays Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Plasma Assays Sales Model
8.5.2 Sales Channel
8.5.3 Plasma Assays Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

List of Tables
Table 1. Plasma Assays Market Trends
Table 2. Plasma Assays Market Drivers & Opportunity
Table 3. Plasma Assays Market Challenges
Table 4. Plasma Assays Market Restraints
Table 5. Global Plasma Assays Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Plasma Assays Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Plasma Assays Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Plasma Assays Product Type
Table 9. Key Companies Time to Begin Mass Production of Plasma Assays
Table 10. Global Plasma Assays Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Assays as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Plasma Assays Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Plasma Assays Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Plasma Assays Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Plasma Assays Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Plasma Assays Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Plasma Assays Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Plasma Assays Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Plasma Assays Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Plasma Assays Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Plasma Assays Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Plasma Assays Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Plasma Assays Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Plasma Assays Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Plasma Assays Sales Value by Region (2019-2024) & (%)
Table 27. Global Plasma Assays Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Plasma Assays Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Plasma Assays Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Plasma Assays Sales Value, (2025-2030) & (US$ Million)
Table 31. Abbott Diagnostics Basic Information List
Table 32. Abbott Diagnostics Description and Business Overview
Table 33. Abbott Diagnostics Plasma Assays Products, Services and Solutions
Table 34. Revenue (US$ Million) in Plasma Assays Business of Abbott Diagnostics (2019-2024)
Table 35. Abbott Diagnostics Recent Developments
Table 36. Roche Diagnostics Basic Information List
Table 37. Roche Diagnostics Description and Business Overview
Table 38. Roche Diagnostics Plasma Assays Products, Services and Solutions
Table 39. Revenue (US$ Million) in Plasma Assays Business of Roche Diagnostics (2019-2024)
Table 40. Roche Diagnostics Recent Developments
Table 41. Danaher Corporation Basic Information List
Table 42. Danaher Corporation Description and Business Overview
Table 43. Danaher Corporation Plasma Assays Products, Services and Solutions
Table 44. Revenue (US$ Million) in Plasma Assays Business of Danaher Corporation (2019-2024)
Table 45. Danaher Corporation Recent Developments
Table 46. Bio-Rad Laboratories Basic Information List
Table 47. Bio-Rad Laboratories Description and Business Overview
Table 48. Bio-Rad Laboratories Plasma Assays Products, Services and Solutions
Table 49. Revenue (US$ Million) in Plasma Assays Business of Bio-Rad Laboratories (2019-2024)
Table 50. Bio-Rad Laboratories Recent Developments
Table 51. Quest Diagnostics Basic Information List
Table 52. Quest Diagnostics Description and Business Overview
Table 53. Quest Diagnostics Plasma Assays Products, Services and Solutions
Table 54. Revenue (US$ Million) in Plasma Assays Business of Quest Diagnostics (2019-2024)
Table 55. Quest Diagnostics Recent Developments
Table 56. Thermo Fisher Scientific Basic Information List
Table 57. Thermo Fisher Scientific Description and Business Overview
Table 58. Thermo Fisher Scientific Plasma Assays Products, Services and Solutions
Table 59. Revenue (US$ Million) in Plasma Assays Business of Thermo Fisher Scientific (2019-2024)
Table 60. Thermo Fisher Scientific Recent Developments
Table 61. Biomerica Basic Information List
Table 62. Biomerica Description and Business Overview
Table 63. Biomerica Plasma Assays Products, Services and Solutions
Table 64. Revenue (US$ Million) in Plasma Assays Business of Biomerica (2019-2024)
Table 65. Biomerica Recent Developments
Table 66. Becton Dickinson & Company Basic Information List
Table 67. Becton Dickinson & Company Description and Business Overview
Table 68. Becton Dickinson & Company Plasma Assays Products, Services and Solutions
Table 69. Revenue (US$ Million) in Plasma Assays Business of Becton Dickinson & Company (2019-2024)
Table 70. Becton Dickinson & Company Recent Developments
Table 71. BioMerieux Basic Information List
Table 72. BioMerieux Description and Business Overview
Table 73. BioMerieux Plasma Assays Products, Services and Solutions
Table 74. Revenue (US$ Million) in Plasma Assays Business of BioMerieux (2019-2024)
Table 75. BioMerieux Recent Developments
Table 76. Siemens Healthcare Basic Information List
Table 77. Siemens Healthcare Description and Business Overview
Table 78. Siemens Healthcare Plasma Assays Products, Services and Solutions
Table 79. Revenue (US$ Million) in Plasma Assays Business of Siemens Healthcare (2019-2024)
Table 80. Siemens Healthcare Recent Developments
Table 81. Trinity Biotech Basic Information List
Table 82. Trinity Biotech Description and Business Overview
Table 83. Trinity Biotech Plasma Assays Products, Services and Solutions
Table 84. Revenue (US$ Million) in Plasma Assays Business of Trinity Biotech (2019-2024)
Table 85. Trinity Biotech Recent Developments
Table 86. Key Raw Materials Lists
Table 87. Raw Materials Key Suppliers Lists
Table 88. Plasma Assays Downstream Customers
Table 89. Plasma Assays Distributors List
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
Table 93. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Plasma Assays Product Picture
Figure 2. Global Plasma Assays Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Plasma Assays Sales Value (2019-2030) & (US$ Million)
Figure 4. Plasma Assays Report Years Considered
Figure 5. Global Plasma Assays Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Plasma Assays Revenue in 2023
Figure 7. Plasma Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Complete Blood Count (CBC) Picture
Figure 9. Glucose testing Picture
Figure 10. Basic Metabolic Panel (BMP) Picture
Figure 11. Blood Urea Nitrogen Testing (BUN) Picture
Figure 12. Global Plasma Assays Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Plasma Assays Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Hospitals
Figure 15. Product Picture of Clinics
Figure 16. Product Picture of Diagnostic Centres
Figure 17. Product Picture of Research Labs
Figure 18. Global Plasma Assays Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Plasma Assays Sales Value Market Share by Application, 2023 & 2030
Figure 20. North America Plasma Assays Sales Value (2019-2030) & (US$ Million)
Figure 21. North America Plasma Assays Sales Value by Country (%), 2023 VS 2030
Figure 22. Europe Plasma Assays Sales Value (2019-2030) & (US$ Million)
Figure 23. Europe Plasma Assays Sales Value by Country (%), 2023 VS 2030
Figure 24. Asia Pacific Plasma Assays Sales Value (2019-2030) & (US$ Million)
Figure 25. Asia Pacific Plasma Assays Sales Value by Country (%), 2023 VS 2030
Figure 26. South America Plasma Assays Sales Value (2019-2030) & (US$ Million)
Figure 27. South America Plasma Assays Sales Value by Country (%), 2023 VS 2030
Figure 28. Middle East & Africa Plasma Assays Sales Value (2019-2030) & (US$ Million)
Figure 29. Middle East & Africa Plasma Assays Sales Value by Country (%), 2023 VS 2030
Figure 30. Key Countries/Regions Plasma Assays Sales Value (%), (2019-2030)
Figure 31. United States Plasma Assays Sales Value, (2019-2030) & (US$ Million)
Figure 32. United States Plasma Assays Sales Value by Type (%), 2023 VS 2030
Figure 33. United States Plasma Assays Sales Value by Application (%), 2023 VS 2030
Figure 34. Europe Plasma Assays Sales Value, (2019-2030) & (US$ Million)
Figure 35. Europe Plasma Assays Sales Value by Type (%), 2023 VS 2030
Figure 36. Europe Plasma Assays Sales Value by Application (%), 2023 VS 2030
Figure 37. China Plasma Assays Sales Value, (2019-2030) & (US$ Million)
Figure 38. China Plasma Assays Sales Value by Type (%), 2023 VS 2030
Figure 39. China Plasma Assays Sales Value by Application (%), 2023 VS 2030
Figure 40. Japan Plasma Assays Sales Value, (2019-2030) & (US$ Million)
Figure 41. Japan Plasma Assays Sales Value by Type (%), 2023 VS 2030
Figure 42. Japan Plasma Assays Sales Value by Application (%), 2023 VS 2030
Figure 43. South Korea Plasma Assays Sales Value, (2019-2030) & (US$ Million)
Figure 44. South Korea Plasma Assays Sales Value by Type (%), 2023 VS 2030
Figure 45. South Korea Plasma Assays Sales Value by Application (%), 2023 VS 2030
Figure 46. Southeast Asia Plasma Assays Sales Value, (2019-2030) & (US$ Million)
Figure 47. Southeast Asia Plasma Assays Sales Value by Type (%), 2023 VS 2030
Figure 48. Southeast Asia Plasma Assays Sales Value by Application (%), 2023 VS 2030
Figure 49. India Plasma Assays Sales Value, (2019-2030) & (US$ Million)
Figure 50. India Plasma Assays Sales Value by Type (%), 2023 VS 2030
Figure 51. India Plasma Assays Sales Value by Application (%), 2023 VS 2030
Figure 52. Plasma Assays Industrial Chain
Figure 53. Plasma Assays Manufacturing Cost Structure
Figure 54. Channels of Distribution (Direct Sales, and Distribution)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation

Our Clients